Home Top Movers Akebia Therapeutics, Inc. (AKBA) Stock On the Rise Following Progression of Vadadastut’s...

Akebia Therapeutics, Inc. (AKBA) Stock On the Rise Following Progression of Vadadastut’s Commercial Development

Akebia Therapeutics, Inc. (AKBA) stock prices were up by a marginal 0.29% as of the market closing on May 28th, 2021, bringing the price per share up to USD$3.51 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock rise by a significant 9.97%, bringing it up to USD$3.86.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

NDA Submission of Vadadustat

The biopharmaceutical giant and its collaborative partner, Otsuka Pharmaceutical Co., Ltd, announced on June 1st, 2022 that the U.S. Food and Drug Administration (FDA) accepted for filing the New Drug Application for vadadustat. Vadadustat is designed to treat anemia arising from chronic kidney disease (CKD) in adult patients both on dialysis, and otherwise.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Read More

Forecast of Development

The FDA has set a target action date of March 29th, 2022 for the Prescription Drug User Fee Act (PDUFA) and has assigned the application standard review. The FDA is not currently planning to conduct an Advisory Committee meeting to discuss the application. The acceptance of the NDA for vadadustat is a significant milestone for the collaborative duo, AKBA, and Otsuka, as the pair continue to develop a new oral treatment option to patients living with anemia arising from CKD.

Bright Future for Vadadustat

The company is confident in both the clarity of their data, and its quality, and looks forward to collaborating with the FDA during the application review. AKBA continues to work with its collaborative partners to ensure the company is well situated to facilitate a successful commercial launch of vadadustat, pending approval by the FDA.

Global Proliferation

Vadadustat is being developed for commercialization around the world by AKBA and Otsuka, with the treatment forecasted to proliferate the U.S, European, Chinese, Russian, Canadian Australian, Middle Eastern, and other territories. The two companies are also collaborating to prepare a Marketing Authorization Application for vadadustat that is forecasted to be submitted to the European Medicines Agency later in the fiscal year 2021.

Solid Liquidity Position

As of March 31st, 2021, AKBA reported cash, cash equivalents, and available-for-sale securities amounting to USD$272.8 million. The company anticipates allocating the cash resources towards the funding of its existing operating plan beyond the expected launch of vadadustat in the U.S. This forecast hinges on the timely regulatory approval of the treatment, as well as the receipt of associated reulgatory milestones.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Future Outlook for AKBA

Armed with a solid liquidity position, the company is keen to push forward with the commercization and global proliferation of vadadastut, thus ushering in further growth. Current and potential investors are hopeful that AKBA will continue to leverage the resources at its disposal to facilitate significant and sustained increases in shareholder value.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

Drive Shack Inc. (DS) stock soars during after-hour trading, followed by no recent update

Drive Shack Inc. (NASDAQ: DS) stock declined by 3.94% at last close while the DS stock-price surged by 7.38% in the after-hour session. Drive...

SPX Flow Inc. (FLOW) stock surged during current market. Here’s why the stock is sky-rocketing?

SPX Flow Inc. (NASDAQ: FLOW) stock gained by 24.24% in the current market trading session. SPX FLOW, based in Charlotte, works to make the...

Platinum Group Metal Ltd. (PLG) stock surges during after-market trading. Here’s to know what’s happening?

Platinum Group Metal Ltd. (NASDAQ: PLG) stock declined by 8.54% at last close whereas the PLG stock price gains by 7% in the after-market...

TD Holdings Inc. (GLG) stock gains during current market trading. Here’s the recent update

TD Holdings Inc. (NASDAQ: GLG) stock gains by 5.01% in the current market trading session. TD Holdings, Inc. is a service provider in China...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

NeuroMetrix Inc. (NURO) stock plunged during pre-market. Let’s find out why?

NeuroMetrix Inc. (NASDAQ: NURO) stock gained by 18.89% at last close while the NURO stock price losses by -4.12% in the pre-market trading session....

Related News

Veoneer Inc. (VNE) stock shows massive gains during pre-market. What’s driving it high?

Veoneer Inc. (NASDAQ: VNE) stock decline by 1.82% at the last close whereas the VNE stock price gains by 55.19% in the pre-market trading...

AnPac Bio-Medical Sciences Inc. (ANPC) stock soars during pre-market. Here’s what you should know?

AnPac Bio-Medical Sciences Inc. (NASDAQ: ANPC) stock declined by 4.98% at last close however the ANPC stock price gains by 6.96% in the pre-market...

Endeavour Silver Corp. (EXK) stock surged during pre-market trading. Here’s what you should know?

Endeavour Silver Corp. (NASDAQ: EXK) stock declined by 4.97% at the last close whereas the EXK stock price gains by 3.56% in the pre-market...

Here is why Amneal Pharmaceuticals Inc (AMRX) stock soared on Monday?

Amneal Pharmaceuticals Inc. (AMRX) shares rose 7.18% in after-hours on Monday, July 19, 2021, and closed at $4.63 per share. Earlier in the morning,...

Why Applied DNA Sciences Inc. (APDN) stock had a bad Friday?

Applied DNA Sciences Inc. (APDN) shares fell 5.27% in after-hours on Friday, July 16, 2021, at $5.03 per share. Earlier, APDN's stock lost 2.93%...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam